Overview

Effects of Wobenzym® Plus in Healthy, Sportive People After Eccentric Exercise

Status:
Completed
Trial end date:
2014-09-01
Target enrollment:
Participant gender:
Summary
The aim of the current study is to investigate the therapeutic effect and especially the mode of action of Wobenzym® plus, an anti-inflammatory drug containing proteolytic enzymes, on exercise induced muscle damage (eiMD) and recovery time in male amateur sportsmen with medium proficiency level compared to placebo.
Phase:
Phase 4
Details
Lead Sponsor:
Mucos Pharma GmbH & Co. KG
Treatments:
Wobenzym